Effects of a novel feed additive on clinical symptoms and the nasal and cecal microbiome in nursery pigs challenged with PRRSV and Streptococcus suis Authors: Huyen T Tran, Aileen Joy Mercado, Manohar M Lahoti, Raghavendra Rao Murali, Ellen Davis, Stacie Crowder, Brenda de Rodas Published: 2026 ABSTRACT AbstractPorcine reproductive and respiratory syndrome virus (PRRSV) is a major endemic disease in swine, causing significant economic losses to the pork industry. PRRSV infection predisposes pigs to secondary infections, leading to a costly and challenging respiratory disease complex. Effective mitigation strategies are needed to reduce negative impacts of PRRSV on swine health and productivity. This study evaluated the efficacy of a novel feed additive (EP) containing a blend of activated medium-chain fatty acids, phytogenic compounds, and probiotics in PRRSV viral load, clinical symptoms, lung lesions, and nasal and cecal microbiome in nursery pigs experimentally co-challenged with PRRSV and Streptococcus suis. Twenty-six weaned pigs were randomly assigned to three groups: 1) non-challenged fed a control diet (Unchallenged), 2) PRRSV and S. suis co-challenged fed a control diet (Challenged), and 3) PRRSV and S. suis co-challenged fed control diet supplemented with 0.4% EP (Challenged + EP). Pigs were fed their respective diets for 29 days and were monitored for respiratory distress symptoms. On days 10 and 21, subsets of pigs were euthanized and necropsied to evaluate lung lesions, quantify viral load in the lung and serum, and characterize the nasal and cecal microbiome. Challenged pigs showed increased viral loads at days 10 and 21, respiratory distress score, and lung lesion score at day 21, and reduced overall weight gain (P < 0.05) compared to the Unchallenged pigs. The Challenged pigs supplemented with EP had lower PRRS viral load in both serum and lung (day 21; P < 0.05) and tended to have a reduced percentage of lungs affected by pneumonia lesions (day 21; P < 0.10) compared to the Challenged group. The Challenged pigs were enriched with nasal opportunistic bacteria, including Streptococcus, Trueperella, Mycoplasma, Actinobacillus, and Pasteurella (LDA score > 3; P < 0.05). However, EP supplementation reduced the abundance of these bacteria and Klebsiella (LDA score > 3; P < 0.05). Both Unchallenged and Challenged + EP pigs were dominated with cecal Prevotella and Blautia (LDA score > 4; P < 0.05). The Challenged + EP group also demonstrated an enrichment in Blautia and Negativibacillus in both nasal and cecal microbiome. In conclusion, dietary supplementation with EP reduced PRRSV infection severity and decreased enrichment of opportunistic bacteria during co-infection. Introduction Porcine Reproductive and Respiratory Syndrome virus (PRRSV) is one of the most devastating endemic diseases, causing more than 664 million dollars in productivity losses to the swine industry annually (Holtkamp et al. 2013). PRRSV infection results in viremia and induces systemic immune suppression in infected animals (An et al. 2020). In nursery pigs, this disease can cause respiratory distress, depression, lethargy, anorexia, and consequently, poor growth performance, and increased mortality rates (Holtkamp et al. 2013; An et al. 2020). PRRSV-mediated suppression of type I interferon responses compromises host immunity, leading to respiratory microbiome dysbiosis and increased susceptibility to secondary bacterial infections, which can further exacerbate microbial imbalance and drive the development of porcine respiratory disease complex. For example, Streptococcus suis, a bacterium normally residing in the upper respiratory tract of pigs, can become pathogenic under immune-suppressive conditions, such as those following PRRSV infection. Co-infection with S. suis often intensifies the PRRSV-associated clinical symptoms, resulting in greater disease severity compared to infection with either pathogen alone (Thanawongnuwech et al. 2000). Although PRRSV infection is known to predispose pigs to secondary bacterial infections and impair respiratory health and growth performance, there is limited research addressing how this disease, either alone or in conjunction with co-infections, influences the nasal and cecal microbiome of pigs (Chrun et al. 2021). Emerging evidence indicates that fecal microbial diversity and certain bacterial families and species, such as Lachnospiraceae and Bacteroides pectinophilus, may mediate the response of pigs to PRRSV infections or vaccinations (Constance et al. 2021; Argüello et al. 2022). However, further research is needed to provide insights into how PRRSV infection impacts key bacterial markers in the gut and upper respiratory tract and how these microbiome alterations interact with the host and other intestinal pathogens in nursery pigs. The development of effective vaccines to control PRRSV infection has been challenging due to the high genetic and antigenic variability of the virus structure (Rupasinghe et al. 2022). As a result, new technologies to mitigate the negative impact of this disease on pig health are essential. Among various technologies, medium-chain fatty acids (MCFAs), phytogenic compounds, and probiotics have shown significant potential in alleviating the impacts of viral and bacterial diseases in pigs. MCFAs have demonstrated antiviral properties, evidenced by reducing viral replication and modulating immune responses in nursery pigs exposed to viral infections (Crowder et al. 2021; Yang et al. 2022). Additionally, probiotics such as Bacillus species have demonstrated a positive response in inhibiting the growth of respiratory bacteria in pigs and broiler chickens (Guo et al. 2024). Phytogenic compounds, including citrus flavonoids, have been shown to reduce inflammatory responses, viral infectivity, and oxidative stresses (Harborne and Williams, 2000; Tripoli et al. 2007). These compounds also support the gut barrier function and nutrient transport, alleviating intestinal disorders around weaning (Stevens et al. 2022; Paniagua et al. 2023). A novel feed additive, EnduraPig (EP, Fortiva, Arden Hills, MN), combines a blend of activated medium-chain fatty acids, phytogenic compounds, and a microbial cocktail. It has been developed to mitigate respiratory diseases in young pigs and support overall growth performance in PRRSV-positive herds. The objective of this pilot trial was to evaluate the effects of feeding EP on PRRSV viral load, clinical symptoms, lung lesions, and nasal and cecal microbiome of nursery pigs experimentally co-challenged with PRRSV and S. suis. Materials and methods Animal and experimental design The animal trial was conducted at the RTI, LLC (RTI; Brookings, SD) facility. All aspects of animal care, housing, and welfare followed the recommendations of the RTI Animal Care and Use Committee (IACUC) and were managed by RTI personnel. The animal protocol (No. 22-07) was approved by the RTI IACUC before initiation. A total of 26 weaned pigs (Large White ˟ Landrace crossbreed; 18–22 d of age) were used. Pigs were sourced from a farm free of PRRSV, porcine circovirus type 2, Influenza A virus (IVA), and S. suis Serotype ½ ST28, with no prior vaccination for PRRSV or S. suis. Pigs were screened for PRRSV before shipment and within 48 h of arrival using oral fluid samples and polymerase chain reaction (PCR) testing (Klindworth et al. 2013). At arrival (day post-challenge, DPC −8), pigs were assigned to one of three treatments: Unchallenged (n = 6; not challenge and fed a control diet), Challenged (n = 10; co-infected with PRRSV and S. suis and fed the control diet), and Challenged + EP (n = 10; co-infected with PRRSV and S. suis and fed the control diet supplemented with 0.4% of EP). The calculated nutrient composition of the control diet is presented in Table S1. Following treatment assignment, pigs were group penned with one pen per treatment. The Unchallenged group was housed in a separate airspace from the other challenged groups. The two challenged groups were housed in the same room, but in separate pens without direct contact. To prevent cross-contamination, a strict biosecurity protocol was implemented throughout the study. Entry into animal rooms followed a Danish entry protocol, requiring personnel to wear room-specific coveralls over the facility clothing, room-specific boots, bouffant, face mask, and gloves. Furthermore, all husbandry and experimental procedures were completed for Unchallenged pigs prior to entering the room housing the Challenged pigs; otherwise, these tasks were done by dedicated staff. A mandatory 48-h downtime was required before re-entering the Unchallenged room following contact with the Challenged pigs. In addition, mandatory decontamination showering was required after exiting any animal airspaces in any experimental group. All pigs underwent an eight-day acclimation period (DPC −8 to 0) before the challenge protocol. During this time, pigs were fed their respective diets, which continued throughout the remainder of the trial (DPC −8 to 21). All pigs had ad libitum access to feed and water. The treatment and challenge description are presented in Table 1, and the experimental timeline is illustrated in Fig. 1. Experiment and sample collection timeline. Created in part with BioRender.com. Table 1Description of treatment and disease challenge conditions in the study.Treatment1No. of PigsChallengeRouteDiet Unchallenged 6Sterile DMEM (4 mL)IN (2 mL per nare)Control Challenged 10PRRSV NA 174 (4 mL) S. suis Serotype ½ ST 28 (4 mL)IN (2 mL per nare)Control Challenged + EP 10PRRS NA 174 (4 mL) S. suis Serotype ½ ST 28 (4 mL)IN (2 mL per nare)Control + 0.4% EP1EP = EnduraPig. Description of treatment and disease challenge conditions in the study. EP = EnduraPig. PRRSV and Streptococcus suis co-infection model Pre-challenge sample collection Three oral fluid samples were collected from the 26 pigs used in this study, with one sample representing each treatment group. Cotton filament ropes were hung at pig height along the pen walls. Following 48 h acclimation period post-arrival, pigs were given 20–30 min of access to the ropes to ensure adequate saturation with saliva. Once collected, the ropes were placed in plastic bags, wrung into Falcon tubes, and submitted to the Iowa State University Veterinary Diagnostic Laboratory for PRRS PCR testing. After allocation to pens, tonsil scrapings from two pigs/pen (n = 6 total) were collected and submitted to the Iowa State University Veterinary Diagnostic Laboratory (ISU VDL) for S. suis screening by culture and next-generation sequencing, following standard laboratory procedures. PRRSV inoculation After the 8-day acclimation period (DPC 0), the Unchallenged group was sham-inoculated intranasally with sterile Minimum Essential Medium (2 mL/nare; 4 mL total/pig). The Challenged and Challenged + EP groups were intranasally inoculated with PRRSV North American strain 1–7-4 (Iowa State Diagnostic Laboratory, Ames, IA) diluted in Dulbecco’s Modified Eagle’s Medium (DMEM; Corning; Glendale, AZ) containing 2% FBS (Atlas; Fort Collins, CO) to a concentration of 1 × 106 TCID50 per pig (2 mL/nare; 4 mL total), using a syringe fitted with an atomizing tip. During the intranasal challenge, pigs were adequately restrained, and the inoculum was gradually dispensed into each nare during inhalation, while the pigs remained restrained with their snout elevated to ensure proper inhalation. Streptococcus suis inoculation On DPC 5, the Unchallenged group was sham-inoculated intranasally a second time with sterile Todd-Hewitt broth (2 mL/nare; 4 ml total) containing 5% fetal calf serum. Pigs in Challenged and Challenged + EP groups were inoculated with S. suis serotype ½ ST28 at a concentration of 1 × 109 colony-forming units per 4 mL dose (2 mL/nare). The S. suis serotype ½ ST28 strain was acquired from the Iowa State University Diagnostic Laboratory (Ames, IA) and confirmed positive for muramidase-released protein virulence (mrp) gene by qPCR. The isolate originated from a brain tissue of a clinical pig with PRRS and S. suis co-infection. The inoculant was prepared in Todd-Hewitt broth with 5% fetal calf serum and diluted with Hanks’ balanced salt solution before inoculation. Samples and data collection Sample collection and necropsy evaluation Three days after the PRRSV challenge (DPC 3), one oral fluid sample was collected from each pen to assess PRRSV exposure, as described in the pre-challenged sample collection. All samples were tested using PRRSV PCR. As expected, the oral fluid samples from the Unchallenged pigs were PRRSV-negative, while those from the Challenged and Challenged + EP groups tested positive for PRRSV. Rectal body temperature was measured from all pigs on DPC 0, 5, 10, 14, and 21. Blood samples were collected on the same days using SST vacutainer tubes. Serum was obtained by centrifuging the blood at 1500 × g for 15 min and stored at −80°C until being shipped to ISU VDL for measurement of PRRSV RNA using RT qPCR. On DPC 10, three pigs from the Unchallenged group and five pigs from each of the Challenged and Challenged + EP groups were selected for necropsy. The remaining pigs (Unchallenged group, n = 3; Challenged and Challenged + EP groups, n = 5) were necropsied on DPC 21. Nasal swabs were collected from all pigs on DPC 10 (n = 26) and from the remaining pigs on DPC 21 (n = 13) prior to euthanization with CO2. For nasal sampling, sterile swabs were gently inserted into one nostril at a 45° angle and rotated clockwise and counterclockwise five times. The same swab was then used to sample the contralateral nostril using the same procedure. Cecal contents were also collected from all necropsied pigs on DPC 10 (n = 13) and DPC 21 (n = 13) at the time of euthanasia. Briefly, the ileocecal junction was identified, and the cecum was aseptically opened using sterile scissors. Approximately 1 mL of cecal content was collected and transferred into 2-mL collection tubes using sterile spatula. All nasal swabs and cecal content samples were immediately snap-frozen in liquid nitrogen and stored at −80°C until they were shipped in dry ice to South Dakota State University for subsequent 16S rRNA sequencing (V3-4 region, Illumina Miseq). A site veterinarian performed the necropsy evaluations. Lung, liver, and brain tissues were aseptically collected at necropsy for S. suis culture. If S. suis colonies were recovered from tissue cultures, quantitative PCR was performed to quantify the abundance of S. suis in the respective samples. Samples with PCR evidence of S. suis were subsequently analyzed by next‑generation sequencing to assess the presence of the mrp gene. A sample was classified as S. suis–positive if the mrp gene was detected by next‑generation sequencing. For PRRS-specific macroscopic lung lesions, interstitial pneumonia scores were determined following the method described in a previous publication (Halbur et al. 1995). Each lung lobe was assigned a gross lesion score based on the approximate percentage of the lung volume and the extent of pneumonia observed. The scores were aggregated to estimate the percentage of lung areas visibly affected by pneumonia. For S. suis specific macroscopic lesions, the pleura, pericardium, and peritoneum were also evaluated and scored for serofibrinous or fibrinosuppurative pleuritis, pericarditis, and peritonitis based on the extent and severity observed at necropsy, using a scale of 0 to 3. A score of 0 indicated no visible lesions; 1 indicated mild, focal fibrinous changes or minimal joint effusion; 2 indicated moderate, multifocal fibrinous or fibrinosuppurative exudate with serosal thickening, adhesions, or joint involvement; and 3 indicated severe, diffuse fibrinosuppurative lesions with extensive adhesions or marked joint distension. The articular space was examined for synovial fluid viscosity, the presence of serofibrinous or fibrinosuppurative exudate, synovial hyperplasia, tendon thickening, and eburnation. These lesions were also scored on the same scale (0 = normal, 1 = mild, 2 = moderate, and 3 = severe). For evaluation of PRRSV-specific microscopic lung lesions, one lung section per pig was collected from the areas exhibiting gross lesions and fixed in 10% formalin for histopathologic examination. Sections were evaluated for alterations in tissue architecture indicative of interstitial pneumonia. In pigs without gross lung lesions, a section was taken from the right caudal lobe. Key lesions assessed included lymphomononuclear cells thickening alveolar septa, Type II pneumocyte hypertrophy and hyperplasia, normal and necrotic alveolar histiocytes plugging alveolar lumina, and the peribronchiolar or perivascular lymphoplasmacytic cuffs. The severity of interstitial pneumonia was scored on a scale of 0 to 3 as follows: 0 = normal, 1 = mild focal interstitial pneumonia, 2 = moderate multifocal interstitial pneumonia, and 3 = severe diffuse interstitial pneumonia. For S. suis-specific microlesions, the calvarium was opened and the meninges were evaluated for hyperemia, cloudiness, and presence of serofibrinous-fibrinosuppurative exudate (0 = normal; 1 = mild; 2 = moderate; 3 = severe) with a section of meninges and the associated neuroparenchyma excised and placed in formalin. Clinical observations After the challenge, all pigs were observed twice daily until the end of the trial. Clinical scoring was performed in a blinded manner by a team of two observers. A clinical respiratory disease scoring rubric (Halbur et al. 1995) was used as follows: 0 = normal; 1 = mild dyspnea and/or tachypnea when stressed; 2 = mild dyspnea and/or tachypnea at rest; 3 = moderate dyspnea and/or tachypnea when stressed; 4 = moderate dyspnea and/or tachypnea at rest; 5 = severe dyspnea and/or tachypnea when stressed; and 6 = severe dyspnea and/or tachypnea at rest. Stress was induced daily by the handler holding the pig under their arm and measuring rectal temperature for approximately 30–60 seconds. Performance data collection Total feed consumption for each pen was recorded throughout the trial. The amount of feed added to the feeder and the feed remaining the following day were weighed to determine the total feed consumption by pen and used to estimate the average daily feed intake (ADFI) per pig. Initial body weights were measured upon pig arrival (DPC −8), on DPC 0 (before the PRRSV Challenge), and on necropsy days (DPC 10 and 21). 16S rRNA sequencing and bioinformatics Nasal and cecal swabs were collected and snap-frozen in liquid nitrogen before being submitted to the Scaria Laboratory, Department of Veterinary & Biomedical Sciences, South Dakota State University (Brookings, SD) for DNA extraction and 16S rRNA sequencing. Sequencing was performed on an Illumina MiSeq platform (Illumina, San Diego, CA, USA) using the MiSeq Reagent Kit v3 (600-cycle; cat#MS-102–3003) and following the standard Illumina protocol for library preparation and amplification of V3–V4 hypervariable region of bacterial 16S rRNA gene, as specified in the manufacturer’s guidelines (https://support.illumina.com/documents/documentation/chemistry_documentation/16s/16s-metagenomic-library-prep-guide-15044223-b.pdf). Details of the primer pairs used in this trial are presented in Table 2, and were previously described (Klindworth et al. 2013). Table 2Primer information1.16S Amplicon PCR Forward Primer with adaptor16S Amplicon PCR Reverse Primer with adaptor TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC1The PCR primers were adapted from Klindworth et al. (Klindworth et al. 2013) to target the 16S V3 and V4 regions. Primer information1. The PCR primers were adapted from Klindworth et al. (Klindworth et al. 2013) to target the 16S V3 and V4 regions. The Quantitative Insights into Microbial Ecology (QIIME2; version 2023.5) pipeline (Bolyen et al. 2019a) was used to analyze microbial community of the nasal and cecal samples. Raw sequences were demultiplexed and processed to construct an amplicon sequence variant (ASV) feature table using the Divisive Amplicon Denoising Algorithm 2 (DADA2) package. All features with fewer than 10 sequences or present in fewer than two samples were removed prior to downstream analysis. QIIME2 was subsequently used to analyze alpha diversity, beta diversity, and phylogenetic classifications. Alpha diversity indices, including Shannon, observed features, Pielou’s evenness, and Faith’s Phylogenetic Diversity, were estimated using the alpha-group-significance plugin at a sampling depth of 34,952 sequences per sample. Beta diversity was evaluated using unweighted and weighted UniFrac distance matrices and compared among treatments with the beta-group-significance plugin. A rooted phylogenetic tree was constructed via q2-phylogeny plugin, and taxonomy was assigned to ASV using the SILVA classifier (Quast et al. 2013). Statistical analysis Data on PRRSV RNA, histopathology measures, clinical scores, body weight, and average daily gain (ADG) were analyzed using the GLIMMIX procedure of SAS (SAS 9.4; SAS Institute Inc., Cary, NC, USA). Diets were applied to pens with one pen per treatment, therefore pen was the unit of feed delivery (with descriptive ADFI only), while pig was the experimental unit for BW, ADG, clinical, virology measures, and microbiome outcomes in this pilot study. Initial pig body weight at DPC −8 was used as a covariate in subsequent BW and ADG data analyses to account for initial differences before the administration of dietary treatments or disease challenge. A power transformation (0.1) was applied to respiratory distress scores, and a square root transformation was used for serum viral load data. Rank transformation was used to analyze the lung micro lesion scores on DPC 21. Pre-planned contrasts were conducted to determine the effects of the disease challenge (Challenged vs. Unchallenged) and EP supplementation (Challenged + EP vs. Challenged). Clinical observations were analyzed using Chi-square independence analysis with Fisher’s exact test. Microbial diversity analyses were conducted in QIIME2. The alpha diversity significance was compared among treatments using Kruskal-Wallis tests (Kruskal and Wallis, 1952; Bolyen et al. 2019a), and beta diversity significance was assessed using permutational multivariate analysis of variance (PERMANOVA; 999 permutations). Linear discriminant analysis (LDA) Effect size (LEfSe) (Nicola Segata et al. 2011) was conducted in R (R Core Team, 2023) to identify significant differential biomarkers between treatment groups. Statistical significance was declared at P ≤ 0.05, and tendency was noted at 0.05 < P ≤ 0.10. Results Growth performance Prior to the administration of dietary treatments or the disease challenge (DPC –8), nursery pigs receiving the disease challenge and fed EP had greater BW compared to the Challenged pigs (P = 0.00). Therefore, the BW of DPC −8 was used as a covariate for all subsequent growth data analyses. During the pre-challenged period (DPC −8 to 0), there was no significant difference among treatments on ADG (P = 0.90) or BW (P = 0.13). During the challenged period (DPC 0 to 21), the challenged control and Challenged + EP pigs tended to have a reduced ADG (P = 0.08) compared to the Unchallenged pigs. During the trial (DPC −8 to 21), Challenged pigs had a lower average daily gain (ADG; 0.39 vs. 0.56 kg; P < 0.05) and final BW (17.83 vs. 22.64 kg; P < 0.05) compared to the Unchallenged pigs. A similar response was observed between the Challenged + EP and Challenged group, with no significant difference in final BW at DPC 21 (19.40 vs. 17.83 kg) or ADG (0.44 vs. 0.39 kg) from DPC −8 to 21 (Table 3). The overall descriptive ADFI (d −8 to 21) for the Unchallenged, Challenged, and Challenged + EP treatments were 0.62, 0.45, and 0.51, respectively. Table 3Effects of experimental diets on growth performance of nursery pigs1.Treatments2,3 P valuesUnchallengedChallengedChallenged + EPTreatmentChallenged vs. UnchallengedChallenged vs. Challenged + EP Body weight (kg) DPC -8 6.24 ± 0.786.05 ± 0.507.03 ± 0.530.010.57<0.01 DPC 0 8.97 ± 1.478.78 ± 1.159.90 ± 0.930.130.770.06 DPC 10 12.70 ± 3.9613.60 ± 1.8811.74 ± 1.400.350.500.17 DPC 21 22.64 ± 3.0517.83 ± 3.2819.40 ± 1.980.040.020.40 ADG (kg) days −8 to 0 0.34 ± 0.100.34 ± 0.090.36 ± 0.080.900.990.68 ADG (kg) days 0 to 10 0.35 ± 0.250.41 ± 0.080.35 ± 0.080.740.580.53 ADG (kg), days 0 to 21 0.61 ± 0.210.41 ± 0.320.46 ± 0.220.080.050.65 ADG (kg) days −8 to 21 0.56 ± 0.070.39 ± 0.100.44 ± 0.050.040.020.401DPC: day post-challenge; ADG: average daily gain; ADFI: average daily feed intake. Pig body weight on DPC -8 (before administration of disease challenge) showed significant differences; thus, it was used as a covariate for all growth data analyses.2Unchallenged: Sham-inoculated intranasally with minimum essential media (DPC 0) and Todd Hewitt Broth with 5% calf serum (at DPC 5) and fed a control diet; Challenged: Intranasally challenged with PRRSV (DPC 0) and Streptococcus suis (DPC 5) and fed control diet; Challenged + EP: Intranasally challenged with PRRSV (DPC 0) and S. suis (DPC 5) and fed control diet supplemented with 0.4% EnduraPig.3The first number represents LSMeans and the second number is the SD. Effects of experimental diets on growth performance of nursery pigs1. DPC: day post-challenge; ADG: average daily gain; ADFI: average daily feed intake. Pig body weight on DPC -8 (before administration of disease challenge) showed significant differences; thus, it was used as a covariate for all growth data analyses. Unchallenged: Sham-inoculated intranasally with minimum essential media (DPC 0) and Todd Hewitt Broth with 5% calf serum (at DPC 5) and fed a control diet; Challenged: Intranasally challenged with PRRSV (DPC 0) and Streptococcus suis (DPC 5) and fed control diet; Challenged + EP: Intranasally challenged with PRRSV (DPC 0) and S. suis (DPC 5) and fed control diet supplemented with 0.4% EnduraPig. The first number represents LSMeans and the second number is the SD. Clinical health observations and PRRSV viremia The Challenged and Challenged + EP pigs showed mild respiratory distress, with average scores of 0.47 and 0.32, respectively (Fig. 2A). In contrast, the Unchallenged pigs exhibited no symptoms, validating the respiratory disease challenge model for this study. During the late post-infection challenge (DPC 16–21), respiratory stress was observed in 100% (5/5 pigs) of the Challenged pigs and 80% (4/5 pigs) of the Challenged + EP pigs compared to 0% (0/3 pigs) of the Unchallenged control (P < 0.05; Fig. 2B). Respiratory distress symptoms of nursery pigs post-challenge. Symptoms were scored daily post-challenge (DPC), and the average scores from DPC 0 to 5, 6 to 9, 10 to 15, and 16 to 21 were compared among groups. (A) Average respiratory distress score in each group on DPC 0–21; (B) Percentage of pigs showing respiratory distress symptoms by day. Unchallenged group: Sham-inoculated intranasally with minimum essential media (DPC 0) and todd hewitt broth with 5% calf serum (at DPC 5) and fed a control diet; challenged group: Intranasally challenged with PRRSV (DPC 0) and Streptococcus suis (DPC 5) and fed control diet; challenged EP group: Intranasally challenged with PRRSV (DPC 0) and S. suis (DPC 5) and fed control diet supplemented with 0.4% EnduraPig. Co-infection with PRRSV + S. suis resulted in a significantly higher respiratory distress score (0.47 vs. 0; P < 0.01; Fig. 2A) and percentage of pigs with respiratory distress symptoms on DPC 16–21 (P, treatment < 0.05; Fig. 2B). All challenged pigs tested positive for PRRSV RNA in both serum (DPC 5, 10, 14, and 21) and lung tissues (DPC 10 and 21). Challenged pigs demonstrated an increase in PRRSV RNA copies in the lungs on DPC 21 (P < 0.05) and in serum on DPC 5, 10, 14, and 21 (P < 0.01) compared to Unchallenged pigs (P < 0.05; Table 4). The Challenged + EP pigs had reduced (P < 0.05) viral RNA levels in both lungs and serum on DPC 21 compared to Challenged pigs (Table 4). Table 4PRRSV Viral load in serum and lung tissue.TissueTimepoint, DPC1Treatment2,3 P valuesUnchallengedChallengedChallenged + EPTreatmentChallenged vs. UnchallengedChallenged vs. Challenged + EP Lung4 DPC 100 (0)1.61E + 09 (9.26E + 08)3.30E + 09 (2.12E + 09)0.0330.1630.098DPC 210 (0)2.30E + 08 (1.60E + 08)7.25E + 07 (4.55E + 07)0.0290.0140.040 Serum5 DPC 50 (0)6.67E + 07 (8.12E + 07)2.54E + 07 (1.71E + 07)0.0010.0000.126DPC 100 (0)1.17E + 09 (1.24E + 09)1.11E + 09 (1.14E + 09)0.0030.0010.755DPC 140 (0)8.82E + 07 (6.99E + 07)3.95E + 07 (3.67E + 07)0.0280.0090.204DPC 210 (0)1.24E + 08 (8.11E + 07)3.82E + 07 (2.11E + 07)0.0200.0100.0291DPC: Day post-challenge.2Unchallenged: Sham-inoculated intranasally with minimum essential media (DPC 0) and Todd Hewitt Broth with 5% calf serum (at DPC 5) and fed a control diet; Challenged: Intranasally challenged with PRRSV (DPC 0) and Streptococcus suis (DPC 5) and fed control diet; Challenged + EP: Intranasally challenged with PRRSV (DPC 0) and Streptococcus suis (DPC 5) and fed control diet supplemented with 0.4% EnduraPig.3The initial value indicates LSMeans, while the value in parentheses denotes the SD.4Copies PRRSV RNA per mg lung tissue.5Copies PRRSV RNA per ml serum. PRRSV Viral load in serum and lung tissue. DPC: Day post-challenge. Unchallenged: Sham-inoculated intranasally with minimum essential media (DPC 0) and Todd Hewitt Broth with 5% calf serum (at DPC 5) and fed a control diet; Challenged: Intranasally challenged with PRRSV (DPC 0) and Streptococcus suis (DPC 5) and fed control diet; Challenged + EP: Intranasally challenged with PRRSV (DPC 0) and Streptococcus suis (DPC 5) and fed control diet supplemented with 0.4% EnduraPig. The initial value indicates LSMeans, while the value in parentheses denotes the SD. Copies PRRSV RNA per mg lung tissue. Copies PRRSV RNA per ml serum. On DPC 10, PRRSV-specific pneumonia macro-lesions were present in 40% of Challenged pigs, whereas no lesions were observed in the Unchallenged or Challenged + EP pigs. By DPC 21, 80% of Challenged pigs and 40% of Challenged + EP pigs had lung lesions, while Unchallenged pigs had no lesions (data not shown). The severity of lung lesions was measured by scoring the percentage of lung area covered with pneumonia lesions. The Challenged pigs tended to exhibit a greater percentage of lung lesions, indicating more severe pneumonia compared to Challenged + EP pigs (38 vs. 3.8%; P < 0.10; Table 5). Additionally, micro-lesion scores in the lungs were significantly greater in the Challenged pigs compared to Unchallenged pigs on DPC10 (P < 0.01; Table 5), whereas no significant differences were observed between the Challenged and Challenged + EP pigs for micro-lesions. Table 5Histopathologic measures in pigs.MeasuresTime1Treatments2,3 P, valuesUnchallengedChallengedChallenged + EPTreatmentChallenged vs. UnchallengedChallenged vs. Challenged + EP % of Lungs with pneumonia based on lung lesion score4 DPC 100 (0)27.6 (39.7)0 (0)0.2050.1630.113DPC 210 (0)38 (43.1)3.8 (7.9)0.0880.0510.073 Micro-lesion score5 DPC 100 (0)2.2 (0.84)2.4 (0.89)0.0040.0030.692DPC 210 (0)2.0 (0.0)2.2 (0.5)<0.001<0.0010.2901DPC: Day post-challenge.2Unchallenged: Sham-inoculated intranasally with minimum essential media (DPC 0) and Todd Hewitt Broth with 5% calf serum (at DPC 5) and fed a control diet; Challenged: Intranasally challenged with PRRSV (DPC 0) and Streptococcus suis (DPC 5) and fed control diet; Challenged + EP: Intranasally challenged with PRRSV (DPC 0) and Streptococcus suis (DPC 5) and fed control diet supplemented with 0.4% EnduraPig.3The initial value indicates LSMeans, while the value in parentheses denotes the SD.4Percent of lungs with pneumonia lesions was scored according to a previous publication (Halbur, 1995).5Micro lesion was scored to evaluate the severity of interstitial pneumonia following the scoring rubric: 0 = normal, 1 = mild focal interstitial pneumonia; 2 = moderate multifocal interstitial pneumonia; 3 = severe diffuse interstitial pneumonia. Histopathologic measures in pigs. DPC: Day post-challenge. Unchallenged: Sham-inoculated intranasally with minimum essential media (DPC 0) and Todd Hewitt Broth with 5% calf serum (at DPC 5) and fed a control diet; Challenged: Intranasally challenged with PRRSV (DPC 0) and Streptococcus suis (DPC 5) and fed control diet; Challenged + EP: Intranasally challenged with PRRSV (DPC 0) and Streptococcus suis (DPC 5) and fed control diet supplemented with 0.4% EnduraPig. The initial value indicates LSMeans, while the value in parentheses denotes the SD. Percent of lungs with pneumonia lesions was scored according to a previous publication (Halbur, 1995). Micro lesion was scored to evaluate the severity of interstitial pneumonia following the scoring rubric: 0 = normal, 1 = mild focal interstitial pneumonia; 2 = moderate multifocal interstitial pneumonia; 3 = severe diffuse interstitial pneumonia. Streptococcus suis culture and clinical symptoms On DPC 10 and 21, liver, lung, and brain cultures were negative for S. suis in all pigs, with the exception of one sample from the Challenged group on DPC 10. However, sequencing results indicated that this sample lacked mrp virulence gene, which was used to distinguish the inoculated S. suis strain from commensal isolates. Therefore, this pig was also classified as negative for S. suis in the present study. No pigs exhibited clinical signs consistent with S. suis infection, including neurologic or mobility impairments. Regarding microscopic lesion, one Challenged control pigs had S. suis specific microlesion. Nasal and cecal microbiome of nursery pigs challenged with PRRSV and S. suis The LEfSe analysis indicated that co-infection altered the nasal microbiome of nursery pigs on both DPC 10 and 21 (Fig. 3A and B). On DPC 10, the differential taxa associated with the Challenged pigs included Trueperella, Actinobacillus, Mycoplasma, Pasteurella, Peptostreptococcus, Parvimonas, Alloprevotella, Faecalibacterium, Fusobacterium, Catenisphaera, Peptoniphilus, [Ruminococcus] torques group (LDA ≥ 3; P < 0.05; Fig. 3A). In contrast, taxa significantly associated with the Unchallenged group were Bergeyella, Neisseria, Limosilactobacillus, Parabacteroides, Chryseobacterium, UCG-005, Lactobacillales, [Ruminococcus] gauvreauii group, Eubacterium, and uncultured Ruminococcaceae (LDA ≥ 3; P < 0.05; Fig. 3A). On DPC 21, the Challenged pigs were primarily associated with Trueperella and Lactobacillus (LDA ≥ 3; P < 0.05; Fig. 3B), while the Unchallenged pigs were associated with Eubacterium and Acinetobacter (LDA ≥ 3; P < 0.01; Fig. 3B). PRRSV and Streptococcus suis co-challenge shifted nasal and cecal microbiome of nursery pigs. Differential taxa of the nasal microbiome in the unchallenged and challenged on DPC 10 and 21 were analyzed by linear discriminant analysis (LDA) Effect size (LefSe). (A) Nasal microbiome at DPC 10; (B) Nasal microbiome at DPC 21; (C) Cecal microbiome at DPC 10; (D) Cecal microbiome at DPC 21. We also observed the changes in the cecal microbiome following co-infection. On DPC 10, the differential taxa in cecal samples associated with the Unchallenged pigs included Prevotella, Parabacteroides, Clostridia vadinBB60 group, UCG-004, Christensenellaceae R-7 group, and UCG-009 (LDA ≥ 3; P < 0.05; Fig. 3C). Conversely, the Challenged group was associated with Faecalibacterium, Subdoligranulum, Clostridia UCG-014, [Eubacterium] coprostanoligenes group, uncultured Prevotellaceae, and Catenibacterium (LDA ≥ 3; P < 0.05; Fig. 3C). On DPC 21, the Challenged pigs showed greater enrichment of Ruminococcus, Streptococcus, and [Eubacterium] eligens group (LDA ≥ 3; P < 0.005), while the Unchallenged group was associated with Blautia, Incertae sedis, Oscillospira (LDA ≥ 3; P < 0.05), and Eubacterium (LDA ≥ 3; P = 0.01; Fig. 3D). Impacts of experimental diets on the nasal and cecal microbiome in nursery pigs challenged or unchallenged with PRRSV and S. suis Nasal and cecal microbial alpha and beta diversity The effects of experimental diets on the alpha diversity of the nasal microbiome were evaluated using observed features and the Shannon index (Fig. 4A–D). On DPC 10, no significant differences were observed between the Challenged and Unchallenged groups on either metric. However, the Challenged + EP group tended to have greater observed features and a greater Shannon index compared to Challenged pigs (P < 0.10; Fig. 4A and B), indicating an increased alpha diversity in Challenged + EP pigs. On DPC 21, no significant differences (P > 0.10) were found in either index. Impacts of experimental diets on alpha diversity of the nasal and cecal microbiome of the unchallenged pigs (unchallenged), pigs challenged with PRRSV and Streptococcus suis and fed a control diet (challenged), and pigs challenged with PRRSV and S. suis and fed EnduraPig (challenged EP) on at 10 and 21 days post-infection (DPC). alpha diversity was measured by the observed features and the shannon index. (A) Observed features in nasal samples on DPC 10. (B) Shannon index in nasal samples on DPC 10. (C) Observed features in nasal samples on DPC 21. (D) Shannon index in nasal samples on DPC 21. (E) Observed features in cecal samples on DPC 10. (F) Shannon index in cecal samples on DPC 10. (G) Observed features in cecal samples on DPC 21. (H) Shannon index in cecal samples on DPC 21. Similar to the nasal microbiome, the alpha diversity of cecal microbiome (the observed features and the Shannon index) was not significantly different among treatments on DPC 10 or 21 (Fig. 4E–H). Beta diversity comparisons among treatments were evaluated using unweighted and weighted UniFrac distance matrices (Lozupone and Knight, 2005). On DPC 10, beta diversity of the nasal microbiome differed significantly among treatments (P = 0.001 and P = 0.006, respectively, for weighted and unweighted UniFrac; Fig. 5A and B). By DPC 21, these differences were less profound (Fig. 5C and D), where unweighted UniFrac remained significant, whereas weighted UniFrac did not. This discrepancy could reflect reduced sample size on DPC 21 (n = 3 for Unchallenged and n = 5 for the Challenged and Challenged + EP groups), or the reduced variability in microbial composition later in the study. Impacts of experimental diets on nasal and cecal microbial beta diversity in nursery pigs at 10 and 21 days post-infection (DPC). beta diversity was measured using unweighted and weighted UniFrac distance matrices: (A) weighted UniFrac of nasal samples on DPC 10, (B) Unweighted UniFrac of nasal samples on DPC 10, (C) Weighted UniFrac of nasal samples on DPC 21, (D) Unweighted UniFrac of nasal samples on DPC 21, (E) Weighted UniFrac of cecal samples on DPC 10, (F) Unweighted unifrac of cecal samples on DPC 10, (G) Weighted UniFrac of cecal samples on DPC 21, (H) Unweighted UniFrac of cecal samples on DPC 21. For cecal microbiome, beta diversity tended to differ in the Challenged vs. Unchallenged pigs on DPC 10 for both weighted and unweighted UniFrac (P < 0.10; Fig. 5E and F); however, the differences were observed only for unweighted UniFrac on DPC 21 (P < 0.05; Fig. 5G and H). Nasal and cecal microbial communities in unchallenged, challenged, and challenged + EP pigs On DPC 10, the nasal microbiome across treatments consisted of Firmicutes (46.3%, ranging 39.8 to 51.1%), Proteobacteria (26.4%, ranging 23.5 to 29.7%), Actinobacteriota (16.9%, ranging 13.0 to 21.1%), and Bacteroidota (10.1%, ranging 7.0 to 13.8%) phyla, which collectively accounted for 99.8% of the nasal microbial community (Fig. 6A). At the genus level (Fig. 6B), the top 10 genera of the Unchallenged pigs included Moraxella (25.6%), Rothia (16.1%), Streptococcus (15.1%), Bergeyella (8.7%), Clostridium sensu stricto 1 (5.8%), Blautia (2.7%), Limosilactobacillus (2.5%), Actinobacillus (2.3%), Coprococcus (1.8%), and Neisseria (1.6%). In Challenged pigs, dominant genera included Rothia (17.4%), Streptococcus (17.3%), Moraxella (16.5%), Clostridium sensu stricto 1 (7.9%), Actinobacillus (5.2%), Mycoplasma (3.2%), Bergeyella (3.2%), Trueperella (3.2%) Globicatella (1.7%), and Blautia (1.7%). In Challenged + EP pigs, the most abundant genera were Moraxella (19.5%), Rothia (12.0%), Streptococcus (11.9%), Clostridium sensu stricto 1 (11.5%), Actinobacillus (5.4%), Bergeyella (4.9%), Limosilactobacillus (3.1%), Blautia (3.0%), Mycoplasma (1.8%), and Subdoligranulum (1.5%) (Fig. 6B). Nasal microbial profiles of nursery pigs challenged with PRRSV and Streptococcus suis on 10 and 21 days post-infection (DPC). the microbial composition in nasal samples is presented at (A) phylum level on DPC 10, (B) genus level on DPC 10, (C) phylum level on DPC 21, and (D) genus level on DPC 21. The opportunistic respiratory bacteria (Streptococcus, Actinobacillus, Mycoplasma, and Pasteurella), comprised 18% (sum of 15.1, 2.3, 0.5, and 0.1%, respectively) of the nasal microbiome in the Unchallenged pigs, compared to 27% (sum of 17.3, 5.2, 3.2, and 1.3%, respectively) in the Challenged pigs. The EP supplementation appeared to reduce these opportunistic bacteria, shifting relative abundance of these taxa closer to the Unchallenged pigs (sum of 11.9, 5.4, 1.8, and 0.61%, respectively for Challenged + EP vs. Unchallenged). On DPC 21, the predominant nasal phyla across treatments were Firmicutes (49.1%, ranging from 34.9 to 57.1%), Proteobacteria (28.7%, ranging from 24.4 to 35.5%), Actinobacteriota (11.4%, ranging from 7.8 to 16.2%), Bacteroidota (10.6%, ranging from 6.5 to 13.4%), and Fusobacteriota (0.3%, ranging from 0.03 to 0.7%) (Fig. 6C). At the genus level, the top 10 genera in the Unchallenged pigs were Moraxella (26.9%), Streptococcus (16.4%), Rothia (15.9%), Bergeyella (8.3%), Actinobacillus (4.3%), Clostridium sensu stricto 1 (4.1%), Porphyromonas (2.5%), Neisseria (2.5%), Pasteurella (1.7%), and Limosilactobacillus (1.6%). Challenged pigs were dominated by Streptococcus (22.8%), Moraxella (17.9%), Clostridium sensu stricto 1 (7.4%), Rothia (6.5%), Limosilactobacillus (5.1%), Actinobacillus (5.0%), Trueperella (3.4%), Bergeyella (3.1%), Mycoplasma (3.1%), and Pasteurella (2.1%). The four respiratory opportunistic taxa (Streptococcus, Actinobacillus, Mycoplasma, and Pasteurella) accounted for 32.9% in Challenged pigs compared to 23.4% in Unchallenged pigs. In Challenged + EP pigs, the most dominant genera were Moraxella (17.1%) followed by Streptococcus (12.4%), Limosilactobacillus (8.9%), Rothia (6.7%), Actinobacillus (6.3%), Clostridium sensu stricto 1 (5.5%), Bergeyella (3.6%), Lactobacillus (2.4%), Blautia (2.3%), and Prevotella (2.1%). The data demonstrated a significant reduction in the respiratory opportunistic bacteria (Streptococcus, Actinobacillus, Mycoplasma, and Pasteurella) in the Challenged + EP group as compared to the Challenged group by 12.1% (20.8% vs. 32.9%, respectively). The cecal microbial profiles of the Unchallenged, Challenged, and Challenged + EP nursery pigs were presented in Fig. 7A–D. On DPC 10, across treatments, the major cecal phyla were Firmicutes (70.5%, ranging from 69.7 to 71.2%), Bacteroidota (28.1%, ranging from 26.9 to 28.9%), Actinobacteriota (0.8%, ranging from 0.7 to 0.8%), Proteobacteria (0.4%, ranging from 0.2 to 0.8%), and Spirochaetota (0.2%, ranging from 0.2 to 0.3%) collectively accounting for 99.9% of the cecal microbiome (Fig. 7A). In Unchallenged pigs, the top 25 genera accounted for 82% of the cecal microbiome (Fig. 7B), with the 10 most dominant genera being Clostridium sensu stricto 1 (15.5%), Prevotella (12.1%), Limosilactobacillus (4.5%), Blautia (4.5%), Coprococcus (4.2%), Lactobacillus (3.5%), Terrisporobacter (3.4%), Prevotellaceae NK3B31 group (3.4%), Prevotella 9 (3.0%), and Subdoligranulum (2.9%). Similarly, in Challenged pigs, the most dominant genus was Clostridium sensu stricto 1 (10.2%), Prevotella 9 (9.8%), Limosilactobacillus (9.0%), Lactobacillus (7.1%), Prevotellaceae NK3B31 group (5.8%), Subdoligranulum (5.0%), Prevotella (4.3%), Lachnospiraceae (3.7%), Blautia (3.4%), and Faecalibacterium (3.3%). In the Challenged + EP, the most dominant genus was Clostridium sensu stricto 1 (10.4%), Limosilactobacillus (9.0%), Prevotella 9 (8.4%), Lactobacillus (8.2%), Prevotella (7.0%), Blautia (4.9%), Prevotellaceae NK3B31 group (4.2%), Faecalibacterium (3.3%), Lachnospiraceae (3.2%), and Alloprevotella (3.1%). Cecal microbial communities of nursery pigs challenged with PRRSV and Streptococcus suis on 10 and 21 days post-infection (DPC). The mean relative abundance (%) of different ASVs at the phylum and genus levels in cecal samples is presented as follows: (A) phylum level on DPC 10, (B) genus level on DPC 10, (C) phylum level on DPC 21, and (D) genus level on DPC 21. On DPC 21, the four major phyla (Firmicutes, Bacteroidota, Actinobacteriota, and Proteobacteria) across treatments remained similar to DPC 10 (Fig. 7C). At the genus level (Fig. 7D), in the Unchallenged pigs, Clostridium sensu stricto 1 (12.5%) remained the most dominant genus, while Prevotella increased to 19%, and Lactobacillus and Limosilactobacillus together increased to 16%. Challenged pigs were characterized by Limosilactobacillus (11.8%), Clostridium sensu stricto 1 (9.7%), Lactobacillus (7.4%), and Prevotella spp. (15.7%). In Challenged + EP pigs, Lactobacillus (16.1%) and Limosilactobacillus (9.5%) were the most abundant, followed by Prevotella (6.5%) and Prevotellaceae NK3B31 group (6.1%), Clostridium sensu stricto 1 (5.9%), Lachnospiraceae (5.0%), Coprococcus (4.4%), UCG008 (3.9%) and Blautia (3.5%) (Fig. 7D). Differential significant taxa of the nasal and cecal microbiome of nursery pigs in challenged and challenged + EP pigs The infection enriched nasal taxa associated with opportunistic bacteria, including Trueperella, Actinobacillus, Mycoplasma, and Pasteurella, compared to Unchallenged pigs on DPC 10 (Fig. 3A). Comparison between the Challenged and Challenged + EP pigs showed distinct microbial markers. The LEfSe results revealed that, on DPC 10, Challenged pigs exhibited a greater relative abundance of Streptococcus, Globicatella, Peptostreptococcus, Colidextribacter, and Peptoniphilus (LDA ≥ 3; P < 0.05; Fig. 8A), while Challenged + EP pigs had 18 genera with significant greater abundance (LDA ≥ 3; P < 0.05; Fig. 8A), including the top three most discriminant taxa, Clostridium sensu stricto 1, Limosilactobacillus, and Blautia (LDA ≥ 4; P < 0.05). Differential taxa of the nasal and cecal microbiome in pigs challenged with PRRSV and fed a control diet (challenged) and challenged pigs fed EnduraPig (challenged EP) at 10 and 21 days post-infection (DPC). data were analyzed using linear discriminant analysis (LDA) effect size with a significant threshold of ≤ 0.05 and LDA scores ≥ 3. (A) Nasal microbiome on DPC 10; (B) Nasal microbiome on DPC 21. (C) Cecal microbiome on DPC 10; (D) Cecal microbiome on DPC 21. Bar length represents log 10-transformed LDA scores. Compared to the Challenged + EP pigs on DPC 21, Challenged pigs continued to have a greater abundance of Streptococcus and additionally showed greater Klebsiella and Anaerococcus (LDA ≥ 3; P < 0.05). The Challenged + EP pigs were associated with eight genera including Blautia, Faecalibacterium, [Ruminococcus] torques group, Catenisphaera, uncultured Ruminococcaceae, uncultured Oscillospiraceae, Anaerostipes, and Negativibacillus (Fig. 8B). Regarding the differential cecal microbiome, the results indicated that the Challenged group on DPC 10 exhibited a significant association with genera Subdoligranulum, Roseburia, Dorea, Incertae Sedis, and Pseudoramibacter (LDA ≥ 3; P < 0.05), whereas Prevotella was associated with Challenged + EP pigs (LDA ≥ 3; P < 0.05; Fig. 8C). On DPC 21, Challenged pigs exhibited enrichment of genera T34, Monoglobus, [Eubacterium] coprostanoligenes group, Ligilactobacillus, Marvinbryantia, Romboutsia, [Eubacterium] eligens group, and Lachnospiraceae UCG-001. Conversely, the Challenged + EP pigs were associated with genera Intestinibacter, Blautia, Lachnospiraceae UCG-004, and Negativibacillus (LDA ≥ 3, P < 0.05; Fig. 8D). Discussion This pilot study was conducted to determine the effectiveness of a dietary feed additive on productivity, clinical symptoms, and the microbiome of pigs undergoing a PRRSV and S. suis co-infection, representing disease challenges that occur in commercial swine production. The main results of this study showed a notable increase in serum and lung PRRS viral RNA, higher respiratory distress scores, greater prevalence of respiratory distress symptoms, and pneumonia lesions in the Challenged compared to the Unchallenged pigs. These findings highlight the significant impact of the PRRSV on clinical health. Second, EP supplementation lowered the infection severity, with lower viral RNA levels in both lungs and serum on DPC 21 and reduced macroscopic pneumonia lesion, compared to Challenged pigs. In addition, the Challenged pigs had increased opportunistic respiratory bacteria (Streptococcus, Actinobacillus, Mycoplasma, and Pasteurella) compared to the Unchallenged pigs (27% vs. 18% of the nasal microbiome). The EP supplementation appeared to reduce these opportunistic bacteria, shifting relative abundance of these taxa closer to the Unchallenged pigs (19.7% vs. 18%, respectively for Challenged + EP vs. Unchallenged). Notably, this study found that co-infection challenge resulted in a mild shift in cecal microbiome of pigs, with a tendency of difference in beta diversity on DPC 10. Both Unchallenged and Challenged + EP pigs showed a strong association with Prevotella (DPC10) and Blautia (DPC 21). The EP group also demonstrated a consistent enrichment in Blautia and Negativibacillus, taxa associated with short-chain fatty acid production and enhanced gut barrier function, in both nasal and cecal microbiome. Collectively, the data showed evidence that EP supplementation promoted the changes in microbiome toward the unchallenged state. Streptococcus suis is a common commensal bacteria in the upper respiratory tract of healthy pigs, and the presence of S. suis does not always result in the onset of clinical symptoms. However, S. suis can become pathogenic under certain circumstances, causing pneumonia, meningitis, arthritis, or septicemia. Factors influencing this pathogenic shift can vary, including bacterial virulence, management practices, and host immune status, particularly immunosuppression associated with PRRSV infection (Obradovic et al. 2021). These observations agree with previous reports (Thanawongnuwech et al. 2000; Domestic Disease Monitoring Report, 2024) that PRRSV and S. suis co-infections are frequently found in the swine herds and result in increased morbidity and mortality in weaned pigs. Despite the dual challenge, S. suis was not recovered from lung or brain culture in any samples, indicating that the clinical observations in the Challenged pigs in this study were predominantly attributable to PRRSV infection. Several factors may contribute to the limited effectiveness of the S. suis challenge, including the isolate viability and preservation, inoculation dose and route, immune status of the pigs, and sampling methods. The lack of S. suis recovery from lung tissues suggests that bacterial colonization was limited or transient and did not persist at detectable levels at the time of sampling. Similarly, the absence of S. suis in brain cultures may indicate that bacterial dissemination did not progress to central nervous system, which is consistent with the lack of neurological signs in challenged pigs. Thus, evaluation of EP supplementation provided insight only into its potential to mitigate PRRSV-associated respiratory symptoms, pneumonia lesion, and microbial profiles in challenged pigs, and interpretation of these results should therefore focus on the effects of PRRSV, as S. suis was not recovered in this study. Pig BW and ADG were measured to validate that the infection challenge model reduced pig growth metrics. Analysis of the data demonstrated that Challenged pigs had a substantial reduction in BW and ADG compared to their Unchallenged contemporaries 21 days after the administration of the disease challenges, indicating that the infection affected productivity of the pigs. Respiratory distress scores remained low throughout the study, with pigs in the Challenged and Challenged + EP groups exhibiting only low respiratory distress scores, despite clear evidence of PRRSV infection, including viremia, lung lesions, and impaired growth performance. This disconnect between respiratory signs and underlying biological responses has been previously documented in nursery pigs experimentally challenged with PRRSV (Niederwerder 2015) and reflects the clinical variability inherent to PRRSV infection. In the present study, the absence of mrp-positive S. suis in tissue cultures further likely contributed to the observed mild respiratory symptoms. Regarding the nasal microbiome, over 99% of the nasal microbiome of the uninfected pigs is composed of the four phyla Firmicutes, Proteobacteria, Bacteroidota, and Actinobacteria. At the genus level, Moraxella was the most dominant genus colonized in the nasal cavity of the unchallenged pigs post-weaning. These data agree with previous publications (Slifierz et al. 2015; Saade et al. 2020; Chrun et al. 2021; Pirolo et al. 2023). Intranasal infection of pigs with PRRSV and S. suis shifted the bacteria toward lower Moraxella while increasing the bacteria associated with respiratory disease complex, such as Streptococcus, Mycoplasma, Actinobacillus, and Pasteurella. Our data agree with previous publications, which indicated pneumonia in PRRSV-infected pigs is associated with secondary pulmonary infections, which are caused by Pasteurella multocida, Streptococcus suis, Streptococcus spp., Glaesserella parasuis, Mycoplasma hyopneumoniae, Bordetella bronchiseptica, and Actinobacillus pleuropneumoniae (Thacker et al. 1999; Saade et al. 2020; Chrun et al. 2021). Mycoplasma hyopneumoniae can increase susceptibility of pigs to PRRSV infection and worsen clinical outcomes (Thacker et al. 1999). These findings suggested that PRRSV infection can shift the nasal microbiome to potentiate viral pathogenicity in pigs. The results of this trial also align with the literature on the role of microbiome in other respiratory infections. In an Influenza A model, it was suggested that nasal microbial diversity has an important role in the pathogenesis of the virus and can be used to predict infection outcomes in neonatal pigs (Yuan et al. 2024). Additionally, a review by Zheng et al. (Zheng et al. 2020) indicated that microbiota is crucial in regulating the immune system by producing cytokines and chemokines and activating immune cells such as NK cells and T cells, which can combat viral infections. In PRRSV infection, the virus can suppress cytokine production and disrupt interferon signaling, including IFN-gamma, thereby weakening the immunity of pigs and predisposing the pigs to secondary infections (Beura et al. 2010). These immune modulations may, in turn, be associated with disruptions in the microbiome, potentially worsening disease prognosis. The greatest changes in nasal bacteria by supplementing EP were observed on DPC 10. At this timepoint, co-infection shifted the nasal microbiome of Challenged pigs toward enriching Mycoplasma, Actinobacillus, and Pasteurella. At the same time, Challenged + EP reduced the abundance of these bacteria as well as Streptococcus. The impacts of EP on lowering these aforementioned opportunistic bacteria are very important for alleviating the severity and negative impacts of PRRSV on pig health. Furthermore, Challenged + EP pigs had a greater abundance of Faecalibacterium, Ruminococcus torques group, Lactobacillus, Lachnospiraceae, and Prevotellaceae NK3B31 group, which were shown in previous publications to be negatively correlated with clinical signs and gross lesions of pigs challenged with European PRRSV strains (Argüello et al. 2022) and therefore may help improve performance outcomes post-PRRSV infection. In cecal samples, an increase in the abundance of Prevotella genus, one of the most dominant genera in the pig intestine, was also observed in the cecal samples of Unchallenged and Challenged + EP pigs on DPC 10. Prevotella species are known to metabolize complex carbohydrates such as hemicelluloses and xylans, commonly used in starter pig diets, producing short-chain fatty acids- primarily propionate and acetate, and indirectly contributing to butyrate production, which can enhance epithelial integrity, reduce inflammation, and support nutrient utilization (Amat et al. 2020; Mahmud et al. 2023). These observations highlight the potential of EP supplementation to mitigate intestinal and respiratory microbial dysbiosis from PRRSV infection. The impact of co-infection was less substantial on DPC 21; however, the dysbiosis of the nasal microbiome still existed during this time, indicating the incomplete microbial recovery. We observed a greater level of Streptococcus spp. on Challenged pigs, while Challenged + EP reduced Streptococcus and Klebsiella, shifting the nasal microbiome toward a profile more similar to Unchallenged pigs. Feeding EP on DPC 21 increased Blautia, Ruminococcus torques group, Faecalibacterium, and Negativibacillus, in which Blautia and Negativibacillus were enriched in both nasal and cecal tissues. These taxa have been shown to be beneficial for pig performance outcomes and health post-PRRSV infection (Sokol et al. 2008; Niederwerder et al. 2016; Chrun et al. 2021). These data support the use of EP to alleviate the impacts of PRRSV on the dysbiosis of the nasal and cecal microbiome. Conclusion Results from this study indicate that supplementation of EP to pigs challenged with PRRSV and S. suis reduced infection severity, lowered relative abundance of nasal opportunistic bacteria, and decreased incidence and severity of pneumonia lesions. These findings suggest that EP may help mitigate the adverse outcomes of the PRRSV infection under the conditions of this study. In addition, this study also provides insights into the potential interactions between the intestinal and respiratory microbiome during PRRSV infection, highlighting the role of microbial community dynamics in disease progression and host response. Further research may be needed to validate these observations in larger studies and explore the association between intestinal-respiratory microbiome and pig resilience to PRRSV infection. Supplementary Material